more

Labcorp (LH)

(Delayed Data from NYSE)

$234.38 USD

+5.27 (2.30%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $234.35 -0.03 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Zacks News

Here's Why You Should Invest in OPKO Health (OPK) Stock Now

by Zacks Equity Research Published on July 06,2020

OPKO Health (OPK) continues to benefit from lucrative prospects in RAYALDEE and BioReference platforms.

Luminex Boosts Product Portfolio With New xMAP Technology

by Zacks Equity Research Published on July 06,2020

Luminex (LMNX) commences rollout of new xMAP INTELLIFLEX Systems, which will expand its xMAP Technology.

3 Cheap MedTech Stocks Set to Gain Once Coronavirus Crisis Ebbs

by Sriparna Ghosal Published on July 06,2020

Once the pandemic-led crisis eases, these MedTech stocks will likely flourish on the back of number of positive developments.

medical

IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

by Zacks Equity Research Published on July 03,2020

IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.

medical

Boston Scientific's (BSX) ICM System Receives FDA Approval

by Zacks Equity Research Published on July 03,2020

Boston Scientific's (BSX) new ICM System gets the FDA's nod, thus paving way for better detection and treatment of arrhythmias.

medical

Here's Why You Should Retain DaVita in Your Portfolio Now

by Zacks Equity Research Published on July 03,2020

Investor confidence is high on DaVita (DVA), thanks to solid prospects.

medical

Myriad Genetics Unveils New Home DNA Sample Collection Kit

by Zacks Equity Research Published on July 02,2020

Myriad Genetics' (MYGN) home DNA sample collection test kit for its GeneSight Psychotropic test enables physicians to remotely provide treatment options to patients with mental health issues.

4 Cheap MedTech Stocks Poised to Beat Industry Post-Pandemic

by Debanjana Dey Published on July 01,2020

Here are some MedTech stocks which might be a solid investment option post the coronavirus blues.

medical

NextGen Virtual Visits Offers Remote Eye Care Facilities

by Zacks Equity Research Published on July 01,2020

The offering will expand NextGen's (NXGN) ophthalmology services during the coronavirus crisis.

medical

Masimo's New Solution to Reduce Opioid Withdrawal Symptoms

by Zacks Equity Research Published on July 01,2020

Masimo's (MASI) new solution can help reduce symptoms associated with opioid withdrawal, thereby helping OUD patients with their treatment.

medical

LabCorp's Xcellerate Coronavirus Solution to Aid Clinical R&D

by Zacks Equity Research Published on June 30,2020

This solution by LabCorp (LH) takes the idea from Covance's COVID-19 Operational Recovery Team to better understand the necessities.

medical

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

by Zacks Equity Research Published on June 30,2020

Allscripts (MDRX) continues to benefit from lucrative deals and strong prospects in Sunrise EHR. However, margin contraction remains a woe.

medical

Luminex Expands COVID-19 Testing With New Antibody Test

by Zacks Equity Research Published on June 30,2020

Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.

medical

LHC Group Inks Deal With Orlando Health to Improve HCBS

by Zacks Equity Research Published on June 30,2020

This deal is expected to boost LHC Group's (LHCG) home and community-based business segment.

medical

Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

by Zacks Equity Research Published on June 29,2020

CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D. However, forex remains a woe.

medical

Masimo's (MASI) New Offering to Improve Patient Outcomes

by Zacks Equity Research Published on June 29,2020

Masimo's (MASI) Centroid gets FDA clearance and can help clinicians monitor patient position, thereby improving patient outcomes.

medical

Ecolab's Unit Unveils Test Kit for Cooling Water Management

by Zacks Equity Research Published on June 29,2020

Ecolab's (ECL) bacteria test kit drastically simplifies water-chemistry testing and compliance for cooling water health.

medical

LabCorp Neutralizing Antibody Test to Aid Coronavirus Vaccine R&D

by Zacks Equity Research Published on June 26,2020

The information related to neutralizing antibody test of LabCorp (LH) can also be used for the screening of convalescent plasma for prophylactic and therapeutic use.